Wantai Biological (603392.SH) released its first three quarters results, with a net loss attributable to shareholders of RMB 231 million.

Zhitong Finance APP News, Wantai Biological (603392.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.623 billion yuan, a year-on-year increase of 8.29%; net profit attributable to the parent company recorded a loss of 231 million yuan, and net profit after deducting non-recurring gains and losses recorded a loss of 286 million yuan; basic earnings per share were -0.18 yuan.